ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Associate Director Master Data Management (MDM) Reltio - Dev at Eli Lilly and Company - ApplyBlast

Associate Director Master Data Management (MDM) Reltio - Dev

Eli Lilly and Company

9 months ago

4.0 on Glassdoor

Hyderabad, India

Hybrid

Full Time

Director

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Associate Director, Master Data Management (MDM) Reltio - Dev at Eli Lilly leads global master data and data engineering efforts to ensure reliable, secure, and compliant enterprise data delivery. The role focuses on building high-performing teams, aligning data systems with commercial business priorities, and communicating strategic data insights to senior leadership.

Skills

Qualifications

Bachelor's or Master's in Computer Science/Information Systems/Data Engineering or related fieldAWS Certified Data Engineer - AssociateDatabricks Certified Data Engineer (Associate or Professional)AWS Certified Architect (Associate or Professional)

About Eli Lilly and Company

lilly.com

Headquarters

Indianapolis, Indiana, United States

Company Size

10001+ employees

Founded

1876

View Profile

Eli Lilly and Company is a global biopharmaceutical company headquartered in Indianapolis, Indiana. It discovers, develops, manufactures and commercializes prescription medicines across therapeutic areas including diabetes, oncology, immunology, neuroscience and pain, and has a longstanding history in insulin and other major drug discoveries. Lilly invests heavily in research and clinical development and partners with biotech, academic institutions, and industry collaborators to advance biologics, small molecules, and precision medicines. The company operates global manufacturing and commercial networks and provides patient-support programs to improve access to its therapies.